 |
 |
Industry Symposia
|
 |
| Thursday January 22 | ||||||
| 15.10 - 16.10 | Auditorium Level -1   |
INCRAFT®, a new development in EVAR Moderator: Jean-Pierre Becquemin, Créteil, France • A First Look at Results from the pivotal INSPIRATION Study of the Ultra-low profile Cordis INCRAFT® AAA Stent Graft System, Michel Makaroun, Pittsburgh, USA • INNOVATION, 3 year clinical follow-up, Giovanni Pratesi, Roma, Italy • My first experience with INCRAFT® Dominique Fabre, Le Plessis-Robinson, France |
||||
| 15.10 - 16.10 |
Room B Level O  |
Added value of Urokinase in the treatment of acute limb ischemia Moderator: Patrick Feugier, CHU Edouard Herriot, Lyon, France • In situ fibrinolysis with Urokinase in the management of acute limb ischemia. Clinical cases: what would you do? Jean Picquet, CHU Angers, France • The use of thrombolysis is a must in vascular surgery 2015, Herman Schroê, CHU Genk, Belgium |
||||
| Friday January 23 | ||||||
| 12.00 - 13.00 |
Auditorium Level -1  |
Latest advancements in DCB as standard of care for Claudicant Patients: IN.PACT Update Chairman: Peter A. Schneider, Kaiser Permanente Medical Center, Honolulu, USA • IN.PACT technology overview and pre-clinical science, Fabrizio Fanelli, Sapienza - Università di Roma, Rome, Italy • IN.PACT clinical evidence update, Fabrizio Fanelli, Sapienza - Università di Roma, Rome, Italy • IN.PACT clinical performances in real world population, Koen Deloose, AZ Sint-Blasius, Dendermonde, BelgiUM • IN.PACT Economic Value proposition, Konstantinos Katsanos, Guy’s and St.Thomas’ Hospitals, London, UK |
||||
| 12.00 - 13.00 |
Room B Level 0  |
Zenith Alpha™ - Designed to give more patients a durable repair Moderator : Michael Dake, Stanford, USA • Aortic aneurysm is a progressive disease, Michel Bartoli, Marseille, France Experiences with Zenith Alpha™ thoracic endovascular graft, • Robert Verhelst, Brussels, Belgium Q&A and Discussions |
||||
| Zilver PTX - 5 years with improved patient outcomes • Zilver® PTX® – 5 year results, Michael Dake, Stanford, USA • Drug eluting technologies - how my patients benefit, Jacques Busquet, Paris, France |
||||||
| 12.00 - 13.00 |
Room C Level 2  |
Femoro-popliteal lesions TASC A & B (< 14cm) : The best option in 2015? • The drug eluting stent as the first choice, Pascal Desgranges, Créteil, France • Drug eluting balloon solution, Hans Krankenberg, Bad Bevensen,Germany • The bare metal stent, the best alternative, Yann Gouëffic, Nantes, France |
||||
| 12.00 - 13.00 |
Room D Level 2  |
Ambulatory! Are you ready? Moderator: Frédéric Mercier, Clinique La Roseraie, Aubervilliers, France • Private Clinic Experience, Rabih Houbballah, Clinique de l’Europe, Port Marly, France • Public Hospital Experience, Pedro Marques Da Fonseca, CHU Cavale Blanche, Brest, France • Main Points and Final Message, Frédéric Mercier, Clinique La Roseraie, Aubervilliers, France |
||||
| Saturday January 24 | ||||||
| 09.20 - 09.50 |
Auditorium Level -1  |
Femoro-popliteal lesions TASC C & D : How to treat them today ? Chairman: Jean-Pierre Becquemin, Créteil, France • Controversy - Simplex bypass ? Laurent Chiche, Paris, France - Extrem Endovascular ? Koen Deloose, Dendermonde, Belgium • Peripheral stenting : single or double antiplatelets ? Massimo Di Primio, Paris, France • Ambulatory Arterial Procedures : Which patients ? Which structure ? Eric Allaire, Créteil, France |
||||
| 11.00 - 11.30 |
Auditorium Level -1  |
Endoleaks Secret Story • Technique, Jean-Pierre Becquemin, Créteil, France • Clinical Results, Dominique Fabre, Le Plessis Robinson, France • Material review |
||||
| 12.40 - 13.10 |
Auditorium Level -1  |
Clinical update on the usage of covered stents Moderator: Jean-Pierre Becquemin, Créteil, France • Visceral and renal stenting - why, when and how to cover your ASS (Athero Sclerotic Stenosis) with V12 RX, Adriaan Moelker, Rotterdam, The Netherlands • Iliac artery stenting and the DISCOVER trial, Bram Fioole, Rotterdam, The Netherlands • Choosing the right stent for BEVAR and FEVAR procedures, Tara Mastracci, London, United Kingdom |
||||
| 14.10 - 14.40 |
Auditorium Level -1  |
Nellix in Europe: from concept to practice • Reasons for selecting EVAS as standard treatment in my practice: experience with 150 patients at St Georges, Matthew Thompson, London, United Kingdom • Place of Nellix as innovative approach in the practice of a French University hospital, Jean-Pierre Becquemin, Créteil, France |
||||
Industry Workshops
|
|
| Friday January 23 | ||||||
| 10.30 - 12.30 |
Workshop room 1 Level 2  |
Type I & II Endoleaks treatment with Onyx™LES : Which use by vascular surgeons ? Thomas Larzon, Orebro, Swedenn • Endoleaks type I – II: how to treat them ? Case review presentation • Endoleaks type I – II: how to prevent them ? Case review presentation • Discussion |
||||
| 14.00 - 16.00 |
Workshop room 1 Level 2 |
French codification and echo Doppler US approach Laurent Casbas, Toulouse, France - Oilivier Pichot, Grenoble, France • EJSF 008 / EJSF 032 : French official codification for RF procedures • Modality & results of radiofrequency for varicose veins treatment • Echo Doppler US approach • Discussion |
||||
| Saturday January 24 | ||||||
| 10.30 - 12.30 | Workshop room 1 Level 2  |
ELVeS 1470nm endovenous laser Workshop Session managed by experts of venous insufficiency and its treatments. Laurence Allouche, Toulouse, France - René Milleret, Montpellier, France • Vein puncture under ultrasound guidance • Interest of tumescence in the endovenous obliteration by laser ELVeS 1470nm • Other indications of the ELVeS 1470nm laser in vascular surgery (small saphenous vein, venous deformations) |
||||
| January 22-24 | ||||||
| |
|
room, Level 0 | ||||
 |
room, Level 0 | |||||
 |
room, Level 1 | |||||
| VASCUTEK France on Terumo group booth | |||||
|
Anaconda simulator & sizing workshop Come to implant the Anaconda repositionable AAA system |
||||